Abstract
Phytanic acid storage disease (Refsum’s disease) has presumably been included in the present Symposium under the rubric “...and Allied Disorders.” In that it is an inherited lipidosis and, like so many of them, affects the nervous system, it is to that extent “allied”. However, the differences are several and important. First, phytanic acid storage disease is due to a defect in an oxidative enzyme system, not a hydrolase; second, it is a disease in which a particular fatty acid accumulates (and in essentially all lipid classes), rather than a particular subclass of lipids as in the hydrolase deficiencies; and, finally, the accumulated lipid is of exogenous rather than endogenous origin. This last difference is especially important since it affords in theory the opportunity to arrest (and possibly reverse) the storage and to determine whether that alters the progression of the disease. Methods are being actively sought to do this in the sphingolipidoses, as reported elsewhere in this Symposium, but the approaches are difficult and results remain equivocal. Thus, it may be of interest to report in some detail our encouraging experience with dietary treatment of phytanic acid storage disease. First, let us briefly review the biochemical basis of phytanate accumulation, add some recent results on the normal pathway for its oxidation and then finally summarize the clinical responses to diet observed to date.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Avigan, J. et al.: Alpha-decarboxylation, An Important Pathway for Degradation of Phytanic Acid in Animals. Biochem. Biophys. Res. Commun. 24: 838, 1966.
Baxter, J.H.: Absorption of Chlorophyll Phytol in Normal Man and in Patients with Refsum’s Disease. J. Lipid Res. 9: 636, 1968.
Baxter, J.H. et al.: Absorption and Metabolism of Uniformly 14Clabeled Phytol and Phytanic Acid by the Intestine of Rat Studied with Thoracic Duct Cannulation. Biochim. Biophys. Acta 137: 277, 1967.
Baxter, J.H. and Steinberg, D.: Absorption of Phytol from Dietary Chlorophyll in the Rat. J. Lipid Res. 8: 615, 1967.
Eldjarn, L. et al.: Dietary Effects on Se_rum Phytanic Acid Levels and on Clinical Manifestations in Heredopathia Atactica Polyneuritiformis. Lancet 1: 691, 1966.
Giovanelli, J. and Stumpf, P.K.: Fat Metabolism in Higher Plants. X. Modified,Q Oxidation of Propionate by Peanut Mitochondria. J. Biol. Chem. 231: 411, 1958.
Hansen, R.P.: Occurrence of 3,7,11,15-Tetramethyl hexadecanoi c Acid in Ox Perinephric Fat. Chem. Industr. 7: 303, 1965.
Hansen, R.P.: 3,7,11,15-Tetramethylhexadecanoic Acid: Its Occurrence in Sheep Fat. N. Zeal. J. Sci. 8: 158, 1965.
Herndon, J.H., Jr., Steinberg, D., Uhlendorf, B.W. and Fales, H.M.: Refsum’s Disease: Characterization of the Enzyme Defect in Cell Culture. J. Cl in. Invest. 48: 1017, 1969.
Herndon, J.H., Jr., Steinberg, D., Uhlendorf, B.W.: Refsum’s Disease: Defective Oxidation of Phytanic Acid in Tissue Cultures Derived from Homozygotes and Heterozygotes. New Eng. J. Med. 281: 1034, 1969.
Hutton, D. and Stumpf, P.K.: Fat Metabolism in Higher Plants. XLII. The Pathway of Rinoleic Acid Catabolism in the Germinating Castor Bean (Rinicus communis L.) and Pea (Pisum sativum L.) Arch. Biochem. Biophys. 142: 48, 1971.
Kahlke, W.: “Heredopathia Atactica Polyneuritiformis (Refsum’s Disease)”, in Lipids and Lipidoses. Schettler, G. (ed) New York: Springer-Verlag, pp. 352–379, 1967.
Kark, R.A.P., Engel, W.K., Blass, J.P., Steinberg, D. and Walsh, G.O.: Heredopathia Atactica Polyneuritiformis (Refsum’s Disease): A Second Trial of Dietary Therapy in Two Patients. Nervous System. Birth Defects: Original Article Series 7: 53, 1971.
Kesner, L. and Muntwyler, E.M.: “Separation of Citric Acid Cycle and Related Compounds by Partition Column Chromatography”, in Methods in Enzymology. Colowick, S.P. and Kaplan, N.O. (eds) New York: Academic Press, Vol. XII, p. 415.
Klenk, E. and Kahlke, W.: Uber das Vorkommen der 3.7.11.15- Tetramethyl hexadecansaure (Phytansaure) in den Cholesterenistern und anderen Lipoidfraktionen der Organe bei einem Krankheitsfall unbekannter Genese (Verdacht auf Heredopathi a atactica polyneurififormisRefsum’s Syndrome). Hoppe Seyler Z Physiol. Chem. 333: 133, 1963.
Klenk, E. and Kremer, G.J.: Untersuchungen zum Stoffwechsel des Phytols, Dihydrophytols und der Phytansaure. Hoppe Seyler Z Physiol. Chem. 343: 39, 1965.
Kolodny, E.H., Hass, W.K., Lane, B. and Drucker, W.D.: Refsum’s Syndrome: Report of a Case Including Electron Microscopic Studies of the Liver. Arch. Neurol. 12: 583, 1965.
Mize, C.E. et al.: A pathway for Oxidative Degradation of Phytanic Acid in Mammals. Biochem. Biophys. Res. Commun. 25: 359, 1966.
Mize, C.E. et al.: Effects of Dietary Phytol and Phytanic Acid in Animals. J. Lipid Res. 7: 684, 1966.
Mize, C.E. et al.: Phytanic Acid Storage in Refsum’s Disease Due to Defective Alpha-Hydroxylation. Clin. Res. 16:346, 1968 (Abs).
Mize, E.C. et al.: A Major Pathway for the Oxidative Degradation of Phytanic Acid. Biochim. Biophys. Acta 176: 720, 1969.
Overath, P., Raufuss, E.M., Stoffel, W. and Ecker, W.: The Induction of Enzymes of Fatty Acid Degradation in E. Col i. Biochem. Biophys. Res. Commun. 29: 28, 1967.
Refsum, S.: HeredopathiaAtactica Polyneuritiformis. Acta Psychiat. Scand. suppl. 38: 1, 1946.
Rosenberg, L., Hsia, Y.E. and Scully, K.J.: Defective Propionate Carboxylation in Ketotic Hyperglycinaemia. Lancet 1: 757, 1969.
Sonnevald, W., Begeman, P.H., van Beers, G.J., Kenning, R. and Schogt, J.0.M.: 3,7,11,15-Tetramethylhexadecanoi c Acid, A Constituent of Butterfat. J. Lipid Res. 3: 351, 1962.
Steinberg, D.: Phytanic Acid Storage Disease, in Metabolic Basis of Inherited Diseases. Stanbury, J.B., Wyngaarden, J.B. andFred-rickson, D.S. (eds) 3rd Edition. New York: McGraw-Hill Book Co., (in press).
Steinberg, D., Avigan, J., Mize, C.E., Baxter, J.H., Cammermeyer, J., Fales, H.M. and Highet, P.F.: Effects of Dietary Phytol and Phytanic Acid in Animals. J. Lipid Res. 7: 684, 1966.
Steinberg, D. and Herndon, J.H., Jr.: Refsum’s Disease, in The Cellular and Molecular Basis of Neurologic Disease. Shy, G.M., Goldensohn, E.S. and Appel, S.H. (eds). Philadelphia: Lea and Febiger, 1971 (in press).
Steinberg, D., Mize, C.E., Avigan, J. Fates, H.M., Eldjarn, L., Try, K. Stokke, O. and Refsum, S.: On the Metabolic Error in Refsum’s Disease. J. Cl in. Invest. 45:1076, 1966 (Abs) .
Steinberg, D. Mize, C.E., Avigan, J., Fales, H.M., Eldjarn, L., Try, K., Stokke, O. and Refsum, S.: Studies on the Metabolic Error in Refsum’s Disease. J. C.in. Invest. 46: 313, 1967.
Steinberg, D., Mize, C.E., Herndon, J.H., Jr., Fales, H.M., Engel, W.K. and Vroom, F,Q.: Phytanic Acid in Patients with Refsum’s Syndrome and Response to Dietary Treatment. Arch. Int. Med. 125: 75, 1970.
Steinberg, D. et al.: Refsum’s Disease - A Recently Characterized Lipidosis Involving the Nervous System. Ann. Int. Med. 66: 365, 1967.
Tsai, S.C. et al.: The Formation of Alpha-hydroxy Phytanic Acid from Phytanic Acid in Mammalian Tissues. Biochem. Biophys. Res. Commun. 28: 571, 1967.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Springer Science+Business Media New York
About this chapter
Cite this chapter
Steinberg, D., Hutton, D. (1972). Phytanic Acid Storage Disease. In: Volk, B.W., Aronson, S.M. (eds) Sphingolipids, Sphingolipidoses and Allied Disorders. Advances in Experimental Medicine and Biology, vol 19. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6570-0_35
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6570-0_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-6572-4
Online ISBN: 978-1-4757-6570-0
eBook Packages: Springer Book Archive